authors
- Szekely, C A
- Kuller, L H
- Psaty, B M
- Resnick, S M
- Wolf, P A
- Zonderman, A B
- Welsh-Bohmer, K A
- Zandi, P P
- Green, R C
- Breitner, J C S
- Østbye, T
- Beiser, A S
- Corrada, M M
- Dodge, H H
- Ganguli, M
- Kawas, C H
No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2008
published in
- Neurology Journal
has subject area
- Acetaminophen
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Alzheimer Disease
- Amyloid beta-Peptides
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents, Non-Steroidal
- Aspirin
- Cohort Studies
- Female
- Humans
- Male
- Middle Aged
- Neuroprotective Agents
- Peptide Fragments
- Proportional Hazards Models
- Prospective Studies
- Risk Factors